Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 14 | 2019 | 596 | 2.040 |
Why?
|
| Cardiac Surgical Procedures | 13 | 2019 | 450 | 1.880 |
Why?
|
| Hypoplastic Left Heart Syndrome | 10 | 2015 | 138 | 1.860 |
Why?
|
| Norwood Procedures | 5 | 2017 | 61 | 1.430 |
Why?
|
| Heart Diseases | 6 | 2019 | 276 | 1.300 |
Why?
|
| Hospital Costs | 4 | 2018 | 117 | 1.290 |
Why?
|
| Postoperative Complications | 12 | 2019 | 1615 | 0.990 |
Why?
|
| Infant | 25 | 2019 | 2891 | 0.910 |
Why?
|
| Pediatrics | 3 | 2015 | 341 | 0.870 |
Why?
|
| Tetralogy of Fallot | 3 | 2018 | 43 | 0.830 |
Why?
|
| Fontan Procedure | 4 | 2011 | 129 | 0.800 |
Why?
|
| Cooperative Behavior | 4 | 2019 | 235 | 0.770 |
Why?
|
| Quality Improvement | 5 | 2019 | 413 | 0.730 |
Why?
|
| Cardiac Catheterization | 3 | 2016 | 419 | 0.720 |
Why?
|
| Pulmonary Artery | 5 | 2010 | 323 | 0.710 |
Why?
|
| Intensive Care Units | 5 | 2021 | 344 | 0.710 |
Why?
|
| Infant, Newborn | 21 | 2020 | 2453 | 0.700 |
Why?
|
| Cardiology | 3 | 2015 | 140 | 0.660 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 2018 | 17 | 0.650 |
Why?
|
| Transposition of Great Vessels | 1 | 2018 | 51 | 0.630 |
Why?
|
| Databases, Factual | 6 | 2019 | 621 | 0.590 |
Why?
|
| Ventricular Pressure | 2 | 2016 | 82 | 0.580 |
Why?
|
| Health Expenditures | 1 | 2018 | 168 | 0.550 |
Why?
|
| Myocardial Contraction | 3 | 2016 | 383 | 0.550 |
Why?
|
| Hospitals, Pediatric | 2 | 2016 | 114 | 0.550 |
Why?
|
| Registries | 7 | 2020 | 730 | 0.550 |
Why?
|
| Echocardiography | 3 | 2016 | 515 | 0.540 |
Why?
|
| Length of Stay | 8 | 2017 | 780 | 0.520 |
Why?
|
| Heart Ventricles | 6 | 2012 | 738 | 0.510 |
Why?
|
| Ventricular Function, Left | 2 | 2016 | 481 | 0.510 |
Why?
|
| Microarray Analysis | 1 | 2014 | 63 | 0.500 |
Why?
|
| Chromosome Aberrations | 1 | 2014 | 86 | 0.500 |
Why?
|
| Cardiopulmonary Bypass | 4 | 2013 | 250 | 0.460 |
Why?
|
| Child, Preschool | 16 | 2019 | 3185 | 0.440 |
Why?
|
| Hypertension, Pulmonary | 2 | 2006 | 232 | 0.430 |
Why?
|
| Leadership | 1 | 2014 | 135 | 0.430 |
Why?
|
| Palliative Care | 4 | 2012 | 271 | 0.420 |
Why?
|
| Hospital Mortality | 8 | 2021 | 384 | 0.400 |
Why?
|
| Humans | 43 | 2021 | 68525 | 0.360 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2006 | 38 | 0.340 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 138 | 0.340 |
Why?
|
| Male | 27 | 2019 | 37281 | 0.340 |
Why?
|
| Child | 16 | 2021 | 6400 | 0.340 |
Why?
|
| Female | 25 | 2019 | 38015 | 0.320 |
Why?
|
| Postoperative Care | 3 | 2017 | 163 | 0.310 |
Why?
|
| Airway Extubation | 2 | 2018 | 17 | 0.310 |
Why?
|
| Heart Bypass, Right | 1 | 2007 | 30 | 0.310 |
Why?
|
| Retrospective Studies | 15 | 2018 | 7264 | 0.310 |
Why?
|
| Intensive Care Units, Pediatric | 4 | 2017 | 101 | 0.300 |
Why?
|
| Vascular Surgical Procedures | 1 | 2008 | 168 | 0.290 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2008 | 186 | 0.290 |
Why?
|
| Heart Valve Diseases | 1 | 2007 | 123 | 0.280 |
Why?
|
| Critical Care | 3 | 2019 | 263 | 0.280 |
Why?
|
| Vasodilation | 1 | 2006 | 85 | 0.270 |
Why?
|
| Extracorporeal Membrane Oxygenation | 4 | 2012 | 123 | 0.270 |
Why?
|
| Preoperative Care | 1 | 2007 | 275 | 0.260 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2005 | 7 | 0.260 |
Why?
|
| United States | 9 | 2019 | 7335 | 0.260 |
Why?
|
| Vasopressins | 1 | 2005 | 33 | 0.260 |
Why?
|
| Vasoconstrictor Agents | 1 | 2005 | 107 | 0.250 |
Why?
|
| Cardiomyopathies | 1 | 2006 | 167 | 0.240 |
Why?
|
| Nitric Oxide | 1 | 2006 | 382 | 0.230 |
Why?
|
| Research Design | 2 | 2020 | 729 | 0.220 |
Why?
|
| Treatment Outcome | 11 | 2015 | 7028 | 0.210 |
Why?
|
| Blalock-Taussig Procedure | 2 | 2012 | 20 | 0.200 |
Why?
|
| Pulmonary Wedge Pressure | 2 | 2016 | 102 | 0.200 |
Why?
|
| Hospital Rapid Response Team | 1 | 2021 | 9 | 0.200 |
Why?
|
| Adolescent | 11 | 2017 | 8903 | 0.190 |
Why?
|
| Respiration, Artificial | 3 | 2017 | 190 | 0.190 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2020 | 9 | 0.190 |
Why?
|
| Heart Arrest | 1 | 2021 | 113 | 0.180 |
Why?
|
| Follow-Up Studies | 4 | 2016 | 3256 | 0.180 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2020 | 113 | 0.180 |
Why?
|
| Cost Savings | 1 | 2020 | 110 | 0.180 |
Why?
|
| Blood Pressure | 2 | 2006 | 1447 | 0.180 |
Why?
|
| Risk Factors | 9 | 2017 | 5719 | 0.180 |
Why?
|
| Heart Transplantation | 2 | 2014 | 328 | 0.180 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2010 | 72 | 0.170 |
Why?
|
| Efficiency, Organizational | 1 | 2019 | 61 | 0.170 |
Why?
|
| Aortic Coarctation | 1 | 2018 | 37 | 0.170 |
Why?
|
| Prospective Studies | 6 | 2016 | 3702 | 0.160 |
Why?
|
| Graft Rejection | 2 | 2014 | 458 | 0.150 |
Why?
|
| Insurance, Health | 1 | 2018 | 200 | 0.150 |
Why?
|
| Cost of Illness | 1 | 2018 | 204 | 0.140 |
Why?
|
| Quality Assurance, Health Care | 1 | 2017 | 177 | 0.140 |
Why?
|
| Intubation, Intratracheal | 1 | 2016 | 99 | 0.140 |
Why?
|
| Clinical Audit | 1 | 2015 | 2 | 0.140 |
Why?
|
| Data Accuracy | 1 | 2015 | 10 | 0.140 |
Why?
|
| Time Factors | 9 | 2018 | 4655 | 0.140 |
Why?
|
| Prenatal Diagnosis | 1 | 2015 | 73 | 0.130 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 848 | 0.130 |
Why?
|
| Vascular Resistance | 2 | 2006 | 179 | 0.130 |
Why?
|
| Tricuspid Valve | 2 | 2013 | 42 | 0.130 |
Why?
|
| Learning | 1 | 2016 | 186 | 0.130 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2007 | 277 | 0.120 |
Why?
|
| Hemodynamics | 4 | 2012 | 705 | 0.120 |
Why?
|
| HLA Antigens | 1 | 2014 | 82 | 0.120 |
Why?
|
| Health Care Rationing | 1 | 2014 | 32 | 0.120 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2013 | 3 | 0.120 |
Why?
|
| Genetic Testing | 1 | 2014 | 159 | 0.120 |
Why?
|
| Heart Injuries | 1 | 2013 | 25 | 0.110 |
Why?
|
| Multiple Trauma | 1 | 2013 | 50 | 0.110 |
Why?
|
| Endpoint Determination | 1 | 2013 | 82 | 0.110 |
Why?
|
| Survival Analysis | 3 | 2012 | 714 | 0.110 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 149 | 0.110 |
Why?
|
| Tissue Donors | 1 | 2014 | 195 | 0.110 |
Why?
|
| Anesthesia | 1 | 2014 | 120 | 0.110 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2013 | 131 | 0.110 |
Why?
|
| Cardiac Output, Low | 1 | 2012 | 52 | 0.100 |
Why?
|
| Tissue and Organ Procurement | 1 | 2014 | 164 | 0.100 |
Why?
|
| Child Development | 1 | 2012 | 102 | 0.100 |
Why?
|
| Risk Assessment | 3 | 2012 | 2004 | 0.100 |
Why?
|
| Developmental Disabilities | 1 | 2012 | 119 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 772 | 0.100 |
Why?
|
| Models, Neurological | 1 | 2012 | 136 | 0.100 |
Why?
|
| Terminal Care | 1 | 2012 | 92 | 0.100 |
Why?
|
| Graft Survival | 1 | 2014 | 465 | 0.100 |
Why?
|
| Age Factors | 2 | 2018 | 1860 | 0.100 |
Why?
|
| Monitoring, Intraoperative | 2 | 2008 | 53 | 0.100 |
Why?
|
| Anastomosis, Surgical | 2 | 2007 | 104 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2010 | 536 | 0.100 |
Why?
|
| Young Adult | 3 | 2017 | 5708 | 0.090 |
Why?
|
| Treatment Failure | 1 | 2011 | 216 | 0.090 |
Why?
|
| Erythrocyte Transfusion | 1 | 2011 | 72 | 0.090 |
Why?
|
| Decision Making | 1 | 2014 | 410 | 0.090 |
Why?
|
| Biomedical Research | 1 | 2014 | 310 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2012 | 222 | 0.090 |
Why?
|
| Patient Selection | 1 | 2014 | 592 | 0.090 |
Why?
|
| Quality of Health Care | 1 | 2012 | 322 | 0.090 |
Why?
|
| Plasma Substitutes | 1 | 2008 | 15 | 0.080 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 1046 | 0.080 |
Why?
|
| Survival Rate | 4 | 2014 | 1055 | 0.080 |
Why?
|
| Resuscitation | 1 | 2008 | 77 | 0.080 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2007 | 36 | 0.080 |
Why?
|
| Liver | 1 | 2013 | 1118 | 0.080 |
Why?
|
| Hyperglycemia | 1 | 2008 | 158 | 0.070 |
Why?
|
| Models, Cardiovascular | 1 | 2007 | 133 | 0.070 |
Why?
|
| Natriuretic Agents | 1 | 2006 | 9 | 0.070 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2006 | 32 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 1465 | 0.070 |
Why?
|
| Pulmonary Veins | 1 | 2006 | 56 | 0.070 |
Why?
|
| Manikins | 1 | 2006 | 42 | 0.070 |
Why?
|
| Patient Care Planning | 1 | 2006 | 108 | 0.070 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2006 | 101 | 0.070 |
Why?
|
| Administration, Inhalation | 1 | 2006 | 187 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2008 | 631 | 0.070 |
Why?
|
| Point-of-Care Systems | 1 | 2006 | 115 | 0.070 |
Why?
|
| Postoperative Period | 3 | 2012 | 238 | 0.060 |
Why?
|
| Hypoxia | 1 | 2006 | 169 | 0.060 |
Why?
|
| Endocarditis, Bacterial | 1 | 2004 | 32 | 0.060 |
Why?
|
| Vascular Patency | 1 | 2005 | 122 | 0.060 |
Why?
|
| Incidence | 3 | 2014 | 1582 | 0.060 |
Why?
|
| Stroke Volume | 1 | 2006 | 586 | 0.060 |
Why?
|
| Biopsy | 1 | 2006 | 539 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2007 | 446 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2006 | 652 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 2004 | 156 | 0.060 |
Why?
|
| Bacteremia | 1 | 2004 | 155 | 0.050 |
Why?
|
| Boston | 2 | 2014 | 35 | 0.050 |
Why?
|
| Cause of Death | 2 | 2012 | 241 | 0.050 |
Why?
|
| South Carolina | 2 | 2020 | 2750 | 0.050 |
Why?
|
| Adult | 5 | 2017 | 21375 | 0.050 |
Why?
|
| Models, Economic | 1 | 2020 | 69 | 0.050 |
Why?
|
| Markov Chains | 1 | 2020 | 133 | 0.040 |
Why?
|
| Morbidity | 1 | 2019 | 130 | 0.040 |
Why?
|
| Inpatients | 1 | 2021 | 208 | 0.040 |
Why?
|
| Perioperative Care | 2 | 2012 | 100 | 0.040 |
Why?
|
| Benchmarking | 1 | 2017 | 91 | 0.040 |
Why?
|
| Prognosis | 2 | 2012 | 2093 | 0.040 |
Why?
|
| Models, Organizational | 1 | 2016 | 97 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2012 | 1745 | 0.030 |
Why?
|
| Ghana | 1 | 2014 | 40 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2011 | 2356 | 0.030 |
Why?
|
| Choice Behavior | 1 | 2014 | 85 | 0.030 |
Why?
|
| Hospitals | 1 | 2015 | 265 | 0.030 |
Why?
|
| Cardiac Output | 1 | 2013 | 133 | 0.030 |
Why?
|
| Hospitalization | 1 | 2018 | 977 | 0.030 |
Why?
|
| North America | 1 | 2012 | 111 | 0.030 |
Why?
|
| Infant Mortality | 1 | 2012 | 59 | 0.030 |
Why?
|
| Ventricular Function | 1 | 2012 | 93 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 2012 | 99 | 0.030 |
Why?
|
| Linear Models | 1 | 2013 | 521 | 0.030 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2010 | 25 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 546 | 0.020 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2010 | 47 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2012 | 517 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2010 | 349 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 880 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2012 | 294 | 0.020 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2010 | 117 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 791 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 1419 | 0.020 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2007 | 33 | 0.020 |
Why?
|
| Systole | 1 | 2007 | 149 | 0.020 |
Why?
|
| Diastole | 1 | 2007 | 161 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2008 | 284 | 0.020 |
Why?
|
| Observer Variation | 1 | 2006 | 330 | 0.020 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2006 | 59 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 361 | 0.020 |
Why?
|
| Insulin | 1 | 2008 | 617 | 0.020 |
Why?
|
| Heart Rate | 1 | 2007 | 568 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 334 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2007 | 601 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2008 | 506 | 0.020 |
Why?
|
| Critical Illness | 1 | 2006 | 191 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2004 | 175 | 0.010 |
Why?
|
| Inflammation | 1 | 2008 | 1030 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2006 | 657 | 0.010 |
Why?
|
| Stents | 1 | 2006 | 657 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 1851 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 2077 | 0.010 |
Why?
|
| Prevalence | 1 | 2004 | 1609 | 0.010 |
Why?
|
| Middle Aged | 1 | 2009 | 21119 | 0.010 |
Why?
|